Business Achievements
Hesperos Provides Support for an Investigational Product for a Phase II Clinical Trial with its Huma
September 24, 2024 02:26 PM Eastern Daylight Time ORLANDO, Fla.--(BUSINESS WIRE)--Hesperos, a leader in recreating human biology for drug discovery, [...]
Advocacy
NEW YORK and MIAMI, Nov. 9, 2023 /PRNewswire/ -- The Parkinson's Foundation has announced it is accepting applications for $1 million in community grant funding. The 2024 [...]
Advocacy
Governor Ron DeSantis announced his Focus on Florida’s Future budget proposal for Fiscal Year (FY) 2
Governor Ron DeSantis announced his Focus on Florida's Future budget proposal for Fiscal Year (FY) 2024–2025. Below is the announcement [...]
Advocacy, Other
Earlier this Week the District Court Granted Summary Judgement to Catalyst in Its Lawsuit Against the FDA and this [...]
Advocacy
This afternoon, Gov. DeSantis signed three bills into law, which take effect July 1, 2024. The press conference was [...]
Industry Events
Alan B. Levan | NSU Broward Center Of Innovation And eMerge Americas Hosted Successful 3rd Annual So
The Alan B. Levan | NSU Broward Center of Innovation (Levan Center of Innovation) and eMerge Americas joined forces to host their 3rd Annual [...]
Business Achievements, Industry Data, Industry Events, People on the Move
President Passidomo, Senators Burton and Harrell Announce “Live Healthy” Proposal to Grow Florida’s Health Care Workforce Legislation Reduces Regulatory Hurdles [...]
Business Achievements, People on the Move
August 08, 2024 07:05 ET| Source: Axogen, Inc. The Board of Directors appoints Michael Dale as new CEO and Director, [...]
Business Achievements, Scientific Advancements
LifeLink® Tissue Bank Aligns with BioTissue’s Sharing Miracles to Promote Regenerative Healing Throu
LifeLink® Tissue Bank Aligns with BioTissue’s Sharing Miracles to Promote Regenerative Healing Through Birth Tissue Therapies FOR IMMEDIATE RELEASE [...]
Advocacy, Scientific Advancements
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is [...]

